Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,933
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
for
Refractory Angina, Coronary Artery Disease
Location: Plano TX, Birmingham AL, Atlanta GA, Cincinnati OH,
Sponsor: XyloCor Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07048808
Phase 2, Recruiting
Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
for
Kidney Transplant Rejection, Cell-free DNA
Location: Dallas TX, Nashville TN, Tampa FL, Jacksonville FL,
Sponsor: Insight Molecular Diagnostics
Sex: All
Age: 18+
Code: NCT07060716
Recruiting
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
for
Peripheral Arterial Disease
Location: Dallas TX, Austin TX, Kingsport TN, Detroit MI,
Sponsor: Baylor Research Institute
Sex: All
Age: 0+
Code: NCT01904851
Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Dallas TX, Temple TX, Houston TX, Saint Joseph MO,
Get alerts for new trials in your area by subscribing now
[18F]PI-2620 Phase 3 Histopathological Study
for
Alzheimer Disease
Location: Dallas TX, Round Rock TX, Kerrville TX, Centerville OH,
Sponsor: Lantheus Biosciences Ltd.
Sex: All
Age: 50+
Code: NCT05641688
Phase 3, Recruiting
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
for
Glioblastoma Multiforme
Location: Dallas TX, Chicago IL, Detroit MI, Durham NC,
Sponsor: Novacea
Sex: All
Age: 18+
Code: NCT00394628
Phase 1, Phase 2, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: Allen TX, Colleyville TX, North Richland Hills TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase 3, Recruiting
IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
for
Postpartum Complication
Location: Dallas TX, Atlanta GA
Sponsor: University of Texas Southwestern Medical Center
Sex: Female
Age: 18+
Code: NCT06218355
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Dallas TX, Tyler TX, Temple TX, Round Rock TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Dallas TX, Oklahoma City OK, Conroe TX, Fort Smith AR,